Caplacizumab is a humanized nanoantibody against von Willebrand factor (vWF). Caplacizumab inhibits vWF-mediated platelet adhesion and prevents further microthrombosis. Caplacizumab can be used in the research of thrombotic thrombocytopenic purpura (TTP).
- Size: 1mg
- Purity: ≥98%
- Brand: Saint Michael
- Catalogue No.: IC5480-1mg
For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.
Write Your Own Review